Compare RAYMED LABS. with GUJ.TERC LAB - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

RAYMED LABS vs GUJ.TERC LAB - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    RAYMED LABS GUJ.TERC LAB RAYMED LABS/
GUJ.TERC LAB
 
P/E (TTM) x -6.0 -21.9 - View Chart
P/BV x - 0.9 - View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 RAYMED LABS   GUJ.TERC LAB
EQUITY SHARE DATA
    RAYMED LABS
Mar-20
GUJ.TERC LAB
Mar-20
RAYMED LABS/
GUJ.TERC LAB
5-Yr Chart
Click to enlarge
High Rs310 29.4%   
Low Rs16 17.0%   
Sales per share (Unadj.) Rs050.6 0.0%  
Earnings per share (Unadj.) Rs-0.10.4 -35.3%  
Cash flow per share (Unadj.) Rs-0.10.7 -16.8%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs-4.615.0 -31.0%  
Shares outstanding (eoy) m4.277.42 57.5%   
Bonus / Rights / Conversions ---  
Price / Sales ratio xNM0.2-  
Avg P/E ratio x-14.820.9 -70.9%  
P/CF ratio (eoy) x-16.611.1 -149.0%  
Price / Book Value ratio x-0.40.5 -80.2%  
Dividend payout %00-   
Avg Mkt Cap Rs m858 14.3%   
No. of employees `000NANA-   
Total wages/salary Rs m0151 0.1%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m0375 0.0%  
Other income Rs m03 4.5%   
Total revenues Rs m0378 0.0%   
Gross profit Rs m-17 -9.2%  
Depreciation Rs m02 2.5%   
Interest Rs m03 0.0%   
Profit before tax Rs m-14 -12.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m02 0.0%   
Profit after tax Rs m-13 -20.3%  
Gross profit margin %NM1.8- 
Effective tax rate %036.6 0.0%   
Net profit margin %NM0.7- 
BALANCE SHEET DATA
Current assets Rs m1119 0.8%   
Current liabilities Rs m2293 24.1%   
Net working cap to sales %NM7.0- 
Current ratio x01.3 3.1%  
Inventory Days DaysNM79- 
Debtors Days DaysNM68- 
Net fixed assets Rs m2104 1.6%   
Share capital Rs m4374 57.6%   
"Free" reserves Rs m-6337 -169.5%   
Net worth Rs m-20111 -17.9%   
Long term debt Rs m02 0.0%   
Total assets Rs m3223 1.2%  
Interest coverage xNM2.5-  
Debt to equity ratio x00 0.0%  
Sales to assets ratio x01.7 0.0%   
Return on assets %-21.72.5 -852.0%  
Return on equity %2.82.5 112.9%  
Return on capital %2.86.5 43.4%  
Exports to sales %NM0.2-  
Imports to sales %NM0-  
Exports (fob) Rs mNA1 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m01 0.0%   
Fx outflow Rs m00-   
Net fx Rs m01 0.0%   
CASH FLOW
From Operations Rs m0-16 0.0%  
From Investments Rs mNA-3 0.0%  
From Financial Activity Rs mNA17 0.0%  
Net Cashflow Rs m0-1 0.0%  

Share Holding

Indian Promoters % 28.4 36.2 78.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 1.0 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 71.6 63.8 112.3%  
Shareholders   1,425 13,277 10.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare RAYMED LABS With:   INDOCO REMEDIES  FDC  AUROBINDO PHARMA  KOPRAN.  ERIS LIFESCIENCES  



Today's Market

Sensex Snaps 7-Day Winning Streak, Nifty Falls Below 18,450; ITC Dips 6%(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views on News

Most Popular

Is it Time to Switch from Tata Power to NTPC?(Profit Hunter)

Oct 11, 2021

Given the huge run up in Tata Power, does it make sense to switch to NTPC?

This Proxy EV Stock Just got a Power Crisis Boost(Profit Hunter)

Oct 8, 2021

After months of research, I've come across few stocks that excite me far more than the mainstream electric vehicle companies.

Rs 1 Lakh Invested in These Cryptos at the Start of 2021 Became Rs...(Views On News)

Oct 8, 2021

These cryptos would have multiplied investors' wealth by as much as 10,000% in just nine months.

Top 5 'Digital India' Stocks(Views On News)

Oct 6, 2021

These companies are leading the Government's US$1 tn 'Digital India' initiative.

5 Exciting 'Unlisted' Companies and How to Play Them(Views On News)

Oct 7, 2021

Here's how you can invest in some of the most exciting start-ups of the decade.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

RAYMED LABS SHARE PRICE


Oct 18, 2021 (Close)

TRACK RAYMED LABS

  • Track your investment in RAYMED LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

RAYMED LABS - SUN PHARMA COMPARISON

COMPARE RAYMED LABS WITH

MARKET STATS